Inactive Instrument

Ocera Therapeutics Inc Stock

Equities

Duration

Period

Style

Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®	17-10-20	GL
Ocera Therapeutics Selected to Present an Oral Presentation and Three Posters on OCR-002 at the AASLD Liver Meeting® 2017	17-08-23	GL
Ocera Therapeutics Reports Second Quarter 2017 Financial Results	17-08-01	GL
Ocera Initiates Phase 2a Study with Oral OCR-002 in Patients with Cirrhosis	17-06-01	GL
Ocera Therapeutics to Host KOL Conference Call on Hepatic Encephalopathy and Other Complications of Liver Disease on Friday, June 2	17-05-26	GL

Sector

	1st Jan change	Capi.
CSL LIMITED	-4.06%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82B
UCB	+56.59%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-15.06%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95B
INCYTE CORPORATION	-16.59%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+6.44%	8.71B
INNOVENT BIOLOGICS, INC.	-7.02%	8.12B